Dysfunction in GABA signalling mediates autism-like stereotypies and Rett syndrome phenotypes. Academic Article uri icon

Overview

abstract

  • Mutations in the X-linked MECP2 gene, which encodes the transcriptional regulator methyl-CpG-binding protein 2 (MeCP2), cause Rett syndrome and several neurodevelopmental disorders including cognitive disorders, autism, juvenile-onset schizophrenia and encephalopathy with early lethality. Rett syndrome is characterized by apparently normal early development followed by regression, motor abnormalities, seizures and features of autism, especially stereotyped behaviours. The mechanisms mediating these features are poorly understood. Here we show that mice lacking Mecp2 from GABA (γ-aminobutyric acid)-releasing neurons recapitulate numerous Rett syndrome and autistic features, including repetitive behaviours. Loss of MeCP2 from a subset of forebrain GABAergic neurons also recapitulates many features of Rett syndrome. MeCP2-deficient GABAergic neurons show reduced inhibitory quantal size, consistent with a presynaptic reduction in glutamic acid decarboxylase 1 (Gad1) and glutamic acid decarboxylase 2 (Gad2) levels, and GABA immunoreactivity. These data demonstrate that MeCP2 is critical for normal function of GABA-releasing neurons and that subtle dysfunction of GABAergic neurons contributes to numerous neuropsychiatric phenotypes.

publication date

  • November 11, 2010

Research

keywords

  • Autistic Disorder
  • Methyl-CpG-Binding Protein 2
  • Rett Syndrome
  • Signal Transduction
  • Stereotypic Movement Disorder
  • gamma-Aminobutyric Acid

Identity

PubMed Central ID

  • PMC3057962

Scopus Document Identifier

  • 78149431869

Digital Object Identifier (DOI)

  • 10.1038/nature09582

PubMed ID

  • 21068835

Additional Document Info

volume

  • 468

issue

  • 7321